Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia

OBJECTIVE: This study sought to examine the effect of ziprasidone on olanzapine or clozapine associated medical morbidity such as insulin resistance, diabetes mellitus and impaired fasting glucose, obesity and hyperlipidemia in patients with schizophrenia or schizoaffective disorder. METHOD: This wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hum Psychopharmacol
Main Authors: Henderson, David C., Fan, Xiaoduo, Copeland, Paul M., Sharma, Bikash, Borba, Christina P., Forstbauer, Sharon I., Miley, Kate, Boxill, Ryan, Freudenreich, Oliver, Cather, Corey, Evins, A. Eden, Goff, Donald C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4327763/
https://ncbi.nlm.nih.gov/pubmed/19283774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hup.1012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados